Home/Filings/4/0001415889-24-017508
4//SEC Filing

Orwin John A 4

Accession 0001415889-24-017508

CIK 0001370053other

Filed

Jun 17, 8:00 PM ET

Accepted

Jun 18, 8:15 PM ET

Size

7.3 KB

Accession

0001415889-24-017508

Insider Transaction Report

Form 4
Period: 2024-06-15
Orwin John A
Director
Transactions
  • Exercise/Conversion

    Common Stock

    2024-06-15+2,0352,035 total
  • Exercise/Conversion

    Restricted Stock Unit

    2024-06-152,0350 total
    Common Stock (2,035 underlying)
Footnotes (2)
  • [F1]Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.
  • [F2]The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2024 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Issuer

ANAPTYSBIO, INC

CIK 0001370053

Entity typeother

Related Parties

1
  • filerCIK 0001477384

Filing Metadata

Form type
4
Filed
Jun 17, 8:00 PM ET
Accepted
Jun 18, 8:15 PM ET
Size
7.3 KB